An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Cisatracurium Besylate Injection
Status: Discontinuation
»Therapeutic Categories: Analgesia/Addiction

AbbVie Inc. (New 09/11/2023)

Company Contact Information:
800-633-9110

Presentation	Posting Date	Related Information
Nimbex, Injection, 2 mg/1 mL (NDC 0074-4378-05)	09/11/2023
Nimbex, Injection, 2 mg/1 mL (NDC 0074-4380-10)	09/11/2023
Nimbex, Injection, 10 mg/1 mL (NDC 0074-4382-20)	09/11/2023

Hospira, Inc., a Pfizer Company (New 04/15/2024)

Company Contact Information:
844-646-4398

Presentation	Posting Date	Related Information
Injection, 10 mg/1 mL (NDC 0409-3670-10)	04/15/2024
Injection, 10 mg/5ml (2 mg/mL) Single Dose Vial PREMIERProRx® (NDC 0409-5547-10)	04/15/2024	Supply expected to exhaust July 2024
Injection, 2 mg/1 mL (NDC 0409-7083-10)	04/15/2024

Top